Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Iron-responsive element-binding protein 2 (IRP2), encoded by the IREB2 gene, is a critical cytosolic RNA-binding protein that functions as the primary sensor and regulator of intracellular iron homeostasis in mammals (UniProt P48200; GeneCards). Unlike its paralog IRP1, IRP2 does not possess aconitase activity and is regulated primarily through iron-dependent proteasomal degradation mediated by the E3 ubiquitin ligase FBXL5 (Wikipedia; NIH). In iron-deficient conditions, IRP2 binds to iron-responsive elements (IREs) in the untranslated regions of target mRNAs, such as ferritin and transferrin receptor 1, to coordinate iron uptake, storage, and export (Frontiers in Pharmacology). This regulatory mechanism is essential for maintaining the labile iron pool required for mitochondrial function, DNA synthesis, and cell survival (NIH). Dysregulation of IRP2 is implicated in several pathologies, including various cancers where its overexpression supports the high iron demands of tumor cells and contributes to therapeutic resistance (NIH; ResearchGate). Conversely, loss of IRP2 function is associated with microcytic hypochromic anemia and progressive neurodegeneration, as seen in both murine models and rare human cases (NIH; OUP). Recent studies have explored IRP2 as a therapeutic target, identifying experimental small-molecule inhibitors like KS-20073 that can sensitize cancer cells to radiation by inducing mitochondrial dysfunction (NIH). Additionally, IRP2 has been linked to the pathogenesis of chronic obstructive pulmonary disease (COPD) and impaired immune responses in inflammatory bowel disease (NIH; ResearchGate).
Binds to iron-responsive elements (IREs) in the untranslated regions (UTRs) of target mRNAs to regulate their translation or stability, thereby controlling cellular iron levels.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Iron-responsive element-binding protein 2 (IRP2) (IRP2).